Literature DB >> 7079750

Human myeloma cell line carrying a Philadelphia chromosome.

A Karpas, P Fischer, D Swirsky.   

Abstract

A new human plasmacytoma cell line (Karpas 707) has been established from a myeloma patient. The cultured cells are negative for Epstein-Barr viral nuclear antigen and free of mycoplasma. They are similar to plasma cells and secrete only lambda light chains. The cells are hypodiploid and contain the Philadelphia chromosome and other abnormalities. This cell line may be suitable for the production of human monoclonal antibodies.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7079750     DOI： 10.1126/science.7079750

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  8 in total

1.  A human myeloma cell line suitable for the generation of human monoclonal antibodies.

Authors:  A Karpas; A Dremucheva; B H Czepulkowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Human monoclonal antibody. Construction of stable clones reactive with human breast cancer.

Authors:  A J Strelkauskas; C L Taylor
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 3.  Human chromosome 22.

Authors:  J C Kaplan; A Aurias; C Julier; M Prieur; M F Szajnert
Journal:  J Med Genet       Date:  1987-02       Impact factor: 6.318

4.  Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.

Authors:  F Caligaris-Cappio; L Bergui; L Tesio; G Pizzolo; F Malavasi; M Chilosi; D Campana; B van Camp; G Janossy
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

5.  Myeloma affects both the growth and function of human osteoblast-like cells.

Authors:  C E Evans; C Ward; L Rathour; C B Galasko
Journal:  Clin Exp Metastasis       Date:  1992-01       Impact factor: 5.150

6.  Establishment of five human myeloma cell lines.

Authors:  M Namba; T Ohtsuki; M Mori; A Togawa; H Wada; T Sugihara; Y Yawata; T Kimoto
Journal:  In Vitro Cell Dev Biol       Date:  1989-08

7.  Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients.

Authors:  M H Ng; A Kan; Y F Chung; I H Wong; K W Lo; N W Wickham; K I Lei; J C Lee
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 8.  Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.

Authors:  Neftali Ortega Alarcon; Maddy Jaramillo; Heidi M Mansour; Bo Sun
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.